Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RETK666N Germline Pathogenic Variant

By sjmartinez • February 18, 2025

Yip AT, Kim TH, Peluso EM, Jacobsen SE, Yeh MW, Lechner MG. Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic Variant. JCEM Case Rep. 2025 Feb 17;3(3):luaf002. doi: 10.1210/jcemcr/luaf002. PMID: 39963300; PMCID: PMC11831074.

Tags: Endocrinology, germline, medullary thyroid carcinoma, MEN2, pathogenic variant, Publications, RET K666N

Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study

Fleseriu M, Biller BMK, Webb SM, Strasburger CJ, Georgescu CE, Bidlingmaier M, Wang C, Baciu I, Casanueva FF, Gilis-Januszewska A, Hart G, Manners A, Choe[...]

Retraction Note: Deficiency of endothelial sirtuin1 in mice stimulates skeletal muscle insulin sensitivity by modifying the secretome

Li Q, Zhang Q, Kim YR, Gaddam RR, Jacobs JS, Bachschmid MM, Younis T, Zhu Z, Zingman L, London B, Rauckhorst AJ, Taylor EB, Norris[...]

Hypothyroidism impairs skeletal muscle regeneration after injury by altering myogenic and nonmyogenic pathways

Aguiari P, Villani V, Liu YY, Carraro G, Brent GA, Perin L, Milanesi A. Hypothyroidism impairs skeletal muscle regeneration after injury by altering myogenic and[...]